United States · 
Who invested in Ukko?
Ukko's investors include Khosla Ventures and Innovation Endeavors.
United States · Series C startup
Who invested in Ukko
Funding summaryUpdated 26 Oct 2026
$45Mraised across 1 round since 2026, from 1 source
- Latest round
- Series C, $45MJan 2026
- Investors
- 2
The rounds
- Jan 2026
Founders and team
From Ukko's own website and the SEC filings it signed: 3 founders, 5 on the team.
- Uri LopatinMd, CEO
- Jeff RonaCFO
- Matt OttmerCOO
- Moshe Ben DavidPhD, CTO
- Prof. Stephen DreskinMedical Director, Allergy and Clinical Immunology
On the board, as filediSamir KaulScott Brady
AdvisersDr. Daniel Adelman
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
These 3 firms list Ukko as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Ukko
How much has Ukko raised?
Ukko has raised $45M across 1 round since 2026.
When did Ukko last raise?
Ukko's most recent round was a Series C of $45M in Jan 2026.
What was Ukko's biggest round?
Its most recent round, $45M in Jan 2026, is also its largest on record.
Who backed Ukko first?
Ukko's first round on record, in Jan 2026, was backed by Khosla Ventures and Innovation Endeavors.
What stage is Ukko at?
Ukko's latest named round is a Series C, in Jan 2026.
Where is Ukko based?
Ukko is based in the United States.
Companies like Ukko
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.